Precigen Inc. (PGEN)
Precigen Statistics
Share Statistics
Precigen has 292.87M shares outstanding. The number of shares has increased by 17.66% in one year.
Shares Outstanding | 292.87M |
Shares Change (YoY) | 17.66% |
Shares Change (QoQ) | 1.79% |
Owned by Institutions (%) | 27.45% |
Shares Floating | 162.39M |
Failed to Deliver (FTD) Shares | 70 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 15.32M, so 5.23% of the outstanding shares have been sold short.
Short Interest | 15.32M |
Short % of Shares Out | 5.23% |
Short % of Float | 9.37% |
Short Ratio (days to cover) | 24.02 |
Valuation Ratios
The PE ratio is -2.45 and the forward PE ratio is -5.71. Precigen's PEG ratio is -0.14.
PE Ratio | -2.45 |
Forward PE | -5.71 |
PS Ratio | 78.72 |
Forward PS | 1.8 |
PB Ratio | 17.3 |
P/FCF Ratio | -4.53 |
PEG Ratio | -0.14 |
Enterprise Valuation
Precigen Inc. has an Enterprise Value (EV) of 327.2M.
EV / Earnings | -2.59 |
EV / Sales | 83.36 |
EV / EBITDA | -2.65 |
EV / EBIT | -2.42 |
EV / FCF | -4.8 |
Financial Position
The company has a current ratio of 4.76, with a Debt / Equity ratio of 0.31.
Current Ratio | 4.76 |
Quick Ratio | 4.76 |
Debt / Equity | 0.31 |
Total Debt / Capitalization | 23.56 |
Cash Flow / Debt | -12.39 |
Interest Coverage | -22504.83 |
Financial Efficiency
Return on equity (ROE) is -7.07% and return on capital (ROIC) is -569.99%.
Return on Equity (ROE) | -7.07% |
Return on Assets (ROA) | -0.87% |
Return on Capital (ROIC) | -569.99% |
Revenue Per Employee | $27,447.55 |
Profits Per Employee | $-882,762.24 |
Employee Count | 143 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.79M |
Effective Tax Rate | 0.01 |
Stock Price Statistics
The stock price has increased by 28.57% in the last 52 weeks. The beta is 1.57, so Precigen's price volatility has been higher than the market average.
Beta | 1.57 |
52-Week Price Change | 28.57% |
50-Day Moving Average | 1.59 |
200-Day Moving Average | 1.25 |
Relative Strength Index (RSI) | 54.79 |
Average Volume (20 Days) | 2.06M |
Income Statement
In the last 12 months, Precigen had revenue of 3.92M and earned -126.23M in profits. Earnings per share was -0.46.
Revenue | 3.92M |
Gross Profit | 3.92M |
Operating Income | -135.03M |
Net Income | -126.23M |
EBITDA | -123.5M |
EBIT | -135.03M |
Earnings Per Share (EPS) | -0.46 |
Balance Sheet
The company has 29.52M in cash and 5.5M in debt, giving a net cash position of 24.02M.
Cash & Cash Equivalents | 29.52M |
Total Debt | 5.5M |
Net Cash | 24.02M |
Retained Earnings | 0 |
Total Assets | 145.27M |
Working Capital | 80.9M |
Cash Flow
In the last 12 months, operating cash flow was -68.17M and capital expenditures 0, giving a free cash flow of -68.17M.
Operating Cash Flow | -68.17M |
Capital Expenditures | 0 |
Free Cash Flow | -68.17M |
FCF Per Share | -0.25 |
Margins
Gross margin is 100%, with operating and profit margins of -3.44K% and -3.22K%.
Gross Margin | 100% |
Operating Margin | -3.44K% |
Pretax Margin | -3.26K% |
Profit Margin | -3.22K% |
EBITDA Margin | -3.15K% |
EBIT Margin | -3.44K% |
FCF Margin | -1.74K% |
Dividends & Yields
PGEN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -25.56% |
FCF Yield | -12.93% |
Analyst Forecast
The average price target for PGEN is $6, which is 233.3% higher than the current price. The consensus rating is "Buy".
Price Target | $6 |
Price Target Difference | 233.3% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | -19.4 |
Piotroski F-Score | 4 |